Our top pick for
Beginners
Finder Award
10X Genomics Inc is a health information services business based in the US. 10X Genomics shares (TXG) are listed on the NASDAQ and all prices are listed in US Dollars. 10X Genomics employs 1,239 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in 10X Genomics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TXG – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
10X Genomics stock price (NASDAQ: TXG)
Use our graph to track the performance of TXG stocks over time.10X Genomics shares at a glance
Information last updated 2022-06-24.
| Latest market close | $46.20 |
|---|---|
| 52-week range | $35.15 - $208.99 |
| 50-day moving average | $48.98 |
| 200-day moving average | $104.74 |
| Wall St. target price | $88.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.80 |
Buy 10X Genomics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy 10X Genomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
10X Genomics price performance over time
Historical closes compared with the close of $46.2 from 2022-06-29
| 1 week (2022-06-24) | -6.91% |
|---|---|
| 1 month (2022-06-01) | 0.13% |
| 3 months (2022-04-01) | -43.05% |
| 6 months (2021-12-31) | -68.98% |
| 1 year (2021-07-01) | -75.68% |
|---|---|
| 2 years (2020-07-01) | -47.50% |
| 3 years (2019-06-27) | N/A |
| 5 years (2017-06-27) | N/A |
Is 10X Genomics stock undervalued or overvalued?
Valuing 10X Genomics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of 10X Genomics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
10X Genomics's EBITDA
10X Genomics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.1 million.
The EBITDA is a measure of a 10X Genomics's overall financial performance and is widely used to measure a its profitability.
10X Genomics financials
| Revenue TTM | $499.2 million |
|---|---|
| Gross profit TTM | $416.4 million |
| Return on assets TTM | -5.4% |
| Return on equity TTM | -11.43% |
| Profit margin | -17.85% |
| Book value | $7.12 |
| Market capitalisation | $5.3 billion |
TTM: trailing 12 months
10X Genomics share dividends
We're not expecting 10X Genomics to pay a dividend over the next 12 months.
Have 10X Genomics's shares ever split?
10X Genomics's shares were split on a 1:2 basis on 16 July 2006. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your 10X Genomics shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for 10X Genomics shares which in turn could have impacted 10X Genomics's share price.
10X Genomics share price volatility
Over the last 12 months, 10X Genomics's shares have ranged in value from as little as $35.15 up to $208.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 10X Genomics's is 1.9146. This would suggest that 10X Genomics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
10X Genomics overview
10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc.
Frequently asked questions
What percentage of 10X Genomics is owned by insiders or institutions?Currently 2.442% of 10X Genomics shares are held by insiders and 99.486% by institutions. How many people work for 10X Genomics?
Latest data suggests 1,239 work at 10X Genomics. When does the fiscal year end for 10X Genomics?
10X Genomics's fiscal year ends in December. Where is 10X Genomics based?
10X Genomics's address is: 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260 What is 10X Genomics's ISIN number?
10X Genomics's international securities identification number is: US88025U1097 What is 10X Genomics's CUSIP number?
10X Genomics's Committee on Uniform Securities Identification Procedures number is: 88025U109
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert